Work

Incidence and Timing of Cancer in HIV-Infected Individuals Following Initiation of Combination Antiretroviral Therapy

Year: 2020

Type: article

Abstract: Cancer is an important cause of morbidity and mortality in individuals infected with human immunodeficiency virus (HIV), but patterns of cancer incidence after combination antiretroviral therapy (ART) initiation remain poorly characterized.

Source: Carolina Digital Repository (University of North Carolina at Chapel Hill)

DOI: 10.17615/mw2m-jf47

Authors: Achenbach, Chad J., Eron, Joseph J., Rodriguez, Benigno, Saag, Michael, Yanik, Elizabeth L., Napravnik, Sonia, Cole, Stephen R., Olshan, Andrew, Kitahata, Mari M., Gopal, Satish, Mugavero, Michael J., Mathews, W. Christopher, Hunt, Peter W., Mayer, Kenneth, Moore, Richard D., Dittmer, Dirk P.

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Bristol-Myers Squibb, Pfizer, GlaxoSmithKline, Harvard University, University of Washington, Johns Hopkins University, Case Western Reserve University, University of Alabama at Birmingham, University of Alabama, National Institutes of Health, University of North Carolina at Chapel Hill, National Institute of Allergy and Infectious Diseases

Awards: G4575219416, G9000036922, G9000075494, G9000081321, Training in Sexually Transmitted Infections and HIV

OpenAlex ID: W4299413744

FWCI:

Cites:

Cited by:

Related to: 10